Contract 75N93022C00003
Rho Federal Systems Division Inc · Department Of Health And Human Services · August 1, 2024
Rho Federal Systems Division Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on August 1, 2024 for $14.01 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Durham, NC. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses cost-plus contract pricing. The most recent modification was on January 30, 2026. If all options are exercised, the contract could reach $40.13 million.
Contract details
- PIID
- 75N93022C00003
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Durham, NC
- First action
- August 1, 2024
- Latest action
- January 30, 2026
Description
AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
Modification timeline
-
January 30, 2026Mod P00011 · Other Administrative Action$40.13M
-
January 29, 2026Mod P00010 · Change Order$40.13M
-
July 29, 2025Mod P00009 · Exercise An Option$32.13M
-
August 1, 2024Mod P00007 · Exercise An Option$24.13M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93022C00003?
Contract 75N93022C00003 is a federal contract awarded to Rho Federal Systems Division Inc by Department Of Health And Human Services on August 1, 2024 for $14.01 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 3 times since the base award.
Who won contract 75N93022C00003?
Rho Federal Systems Division Inc won contract 75N93022C00003 from Department Of Health And Human Services.
How much is contract 75N93022C00003 worth?
Contract 75N93022C00003 has obligated $14.01 million to date, with a total potential value of $40.13 million if all options are exercised.